Quality of life and treatment consequences after breast cancer C50
Conditions
Interventions
Group 1: Intervention
• Use of digital applications and intersectoral and multidisciplinary networking of healthcare providers
• Regular assessment of patient needs
• Use of aftercare passport and ele
Sponsors
Universitätsklinikum Würzburg
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: End of curative primary treatment; consent to participation
Exclusion criteria
Exclusion criteria: metastatic breast carcinoma (palliative therapy approach); lack of digital infrastructure; participation in another structured follow-up program with an intervention via digital application
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life: Registration of change in health-related disease-specific quality of life measured by standardized questionnaires: EORTC QLQ-C30 and EORTC QLQ-BR23. Data is collected at 12 months after inclusion. Objectives of the pilot study are feasibility of recruitment, comprehensiveness and completion of data collection and acceptability of intervention assessed by questionnaire and qualitative interview. | — |
Secondary
| Measure | Time frame |
|---|---|
| Identification of treatment adherence; treatment consequences (e.g., fatigue, neurotoxicity, cardiotoxicity); psychological comorbidities (e.g., anxiety, depression, cognitive impairment); follow-up standards according to guideline; participation in work life and activities of daily living; rehospitalization; progression free survival; patient satisfaction; follow-up costs in the first year (health economic evaluation). | — |
Countries
Germany
Contacts
Public ContactAchim Wöckel
Universitätsklinikum Würzburg Frauenklinik und Poliklinik
Outcome results
None listed